New combo attack on lung cancer before surgery
NCT ID NCT06293690
Summary
This study is testing a new treatment approach for people with operable non-small cell lung cancer. Before surgery, patients receive a drug called toripalimab (an immunotherapy) combined with a precise, high-dose radiation technique called SBRT. The goal is to see if this combination can more effectively shrink or eliminate the tumor, potentially leading to better long-term results after the operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.